Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.710
+0.100 (6.21%)
At close: Apr 15, 2026, 4:00 PM EDT
1.700
-0.010 (-0.58%)
After-hours: Apr 15, 2026, 7:52 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $483.59 million as of April 15, 2026. Its market cap has increased by 565.99% in one year.
Market Cap
483.59M
Enterprise Value
259.40M
1-Year Change
565.99%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $483.59M, a decrease of -78.66%. That is a compound annual growth rate of -28.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 483.59M | -29.35% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 476.81M |
| vTv Therapeutics | 475.66M |
| Armata Pharmaceuticals | 471.83M |
| XOMA Royalty | 469.60M |
| Assembly Biosciences | 467.00M |
| Atea Pharmaceuticals | 462.10M |
| Aura Biosciences | 454.83M |
| Benitec Biopharma | 453.88M |